Mirati Therapeutics, Inc. (NASDAQ:MRTX) Q3 2022 Earnings Call Transcript November 8, 2022
Mirati Therapeutics, Inc. beats earnings expectations. Reported EPS is $-3.09, expectations were $-3.48.
Operator: Good afternoon, and welcome to the Mirati Therapeutics Third Quarter 2022 Earnings Call. My name is Jenny, and I will be the operator for today’s call. All lines have been placed on mute to prevent any background noise. After the conclusion of the speakers prepared remarks, there will be a...
